I speak with enterprise leaders every day, and from the look of it, there's a rare consensus in the ranks: Modernization is no longer optional if companies wish to avoid extinction. Whether the ...
In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics. The agreement grants Roche and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results